You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LCZ696

Showing 51 - 66 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacokinetics, Renal Impaired, Healthy Volunteer Trial in Neuss, Moscow, Belgrade (LCZ696A)

Completed
Has Results
  • Pharmacokinetics
  • +2 more
  • Neuss, Germany
  • +2 more
Aug 27, 2015

Salt-sensitive Hypertension Trial in Worldwide (Valsartan, LCZ696)

Completed
Has Results
  • Salt-sensitive Hypertension
  • Anaheim, California
  • +14 more
Oct 12, 2015

Hepatic Impairment Trial in Grunstadt (LCZ696)

Completed
Has Results
  • Hepatic Impairment
  • LCZ696
  • Grunstadt, Germany
    Novartis Investigative Site
Jul 11, 2015

Hypertension, Concurrent Obesity Trial in Hannover, Neuss, Maastricht (LCZ696, amlodipine, Placebo)

Completed
Has Results
  • Hypertension
  • Concurrent Obesity
  • LCZ696
  • +2 more
  • Hannover, Germany
  • +2 more
Jul 11, 2015

Hypertension Trial in Worldwide (LCZ696, Olmesartan, Placebo of LCZ696)

Completed
Has Results
  • Hypertension
  • LCZ696
  • +3 more
  • Birmingham, Alabama
  • +50 more
Nov 3, 2015

Essential Hypertension Trial in Worldwide (LCZ696, Amlodipine, Placebo)

Completed
Has Results
  • Essential Hypertension
  • LCZ696
  • +2 more
  • Shijiazhuang, Hebei, China
  • +27 more
Oct 1, 2015

Essential Hypertension Trial in Worldwide (LCZ696, Amlodipine, Hydrochlorothiazide (HCTZ))

Completed
Has Results
  • Essential Hypertension
  • LCZ696
  • +2 more
  • Chongqing, Chongqing, China
  • +32 more
Sep 22, 2015

Hypertension With Renal Dysfunction Trial in Japan (LCZ696)

Completed
Has Results
  • Hypertension With Renal Dysfunction
  • LCZ696
  • Sapporo-city, Hokkaido, Japan
  • +12 more
Aug 7, 2015

Heart Failure With Reduced Ejection Fraction Trial in Worldwide (LCZ696 200 mg BID, Enalapril 10 mg BID)

Terminated
Has Results
  • Heart Failure With Reduced Ejection Fraction
  • LCZ696 200 mg BID
  • Enalapril 10 mg BID
  • Birmingham, Alabama
  • +1029 more
Jul 13, 2016

Essential Hypertension Trial in Japan (LCZ696, Olmesartan, Placebo)

Completed
Has Results
  • Essential Hypertension
  • LCZ696
  • +2 more
  • Kamogawa-City, Chiba, Japan
  • +60 more
Sep 25, 2015

Essential Hypertension Trial in Worldwide (Olmesartan, Placebo, LCZ696)

Completed
Has Results
  • Essential Hypertension
  • Chongqing, Chongqing, China
  • +77 more
Oct 1, 2015

Heart Failure With Reduced Ejection Fraction Trial in Worldwide (LCZ696)

Completed
Has Results
  • Heart Failure With Reduced Ejection Fraction
  • LCZ696
  • Anchorage, Alaska
  • +104 more
Sep 16, 2015

Chronic Heart Failure Trial in Worldwide (LCZ696, Valsartan, Placebo)

Completed
Has Results
  • Chronic Heart Failure
  • LCZ696
  • +2 more
  • Little Rock, Arkansas
  • +80 more
Aug 12, 2015

Hypertension Trial in Worldwide (LCZ696, Valsartan, AHU377)

Completed
Has Results
  • Hypertension
  • LCZ696
  • +3 more
  • Birmingham, Alabama
  • +181 more
Aug 11, 2015

Systolic Hypertension Trial in Worldwide (LCZ696, Valsartan, AHU377)

Completed
Has Results
  • Systolic Hypertension
  • LCZ696
  • +3 more
  • Clearwater, Florida
  • +89 more
Dec 22, 2015

Hypertension Trial (LCZ696, Amlodipine, LCZ696 and amlodipine combination)

Withdrawn
  • Hypertension
  • LCZ696
  • +3 more
  • (no location specified)
Aug 4, 2014